Clinical Trials Directory

Trials / Unknown

UnknownNCT03220542

The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori

The Effect of Broccoli Sprout Extract and Probiotics on Proton Pump Inhibitor-based Triple Therapy for Eradication of Helicobacter Pylori: a Prospective Randomized Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
360 (estimated)
Sponsor
Kyunghee University Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In Korea, the first-line therapy to treat Helicobacter pylori (Hp) consists of a proton pump inhibitor (PPI) and two antibiotics for one week. But, eradication has become less successful due to low compliance and high resistance to the antibiotics. Therefore, it is necessary to develop new treatment strategies that increase the eradication rate and reduce adverse effects. In vitro study, we previously reported that a broccoli sprout extract containing sulforaphane may prevent lipid peroxidation in the gastric mucosa and play a cytoprotective role in Hp-induced gastritis. Also, several studies suggested that probiotics could be effective for improving Hp eradication rate or reducing adverse events. But, their effect for eradication of Hp is not yet conclusive. The aims of this prospective study is to investigate the efficacy of a broccoli sprout extract containing sulforaphane and probiotics for eradication of Hp, compared with standard triple therapy.

Conditions

Interventions

TypeNameDescription
DRUGProbioticsSaccharomyces boulardii
DIETARY_SUPPLEMENTBroccoliBroccoli sprouts extract
DRUGEsomeprazoleEsomeprazole
DRUGAmoxicillinAmoxicillin
DRUGClarithromycinClarithromycin

Timeline

Start date
2016-01-01
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2017-07-18
Last updated
2019-06-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03220542. Inclusion in this directory is not an endorsement.